Medicus Pharma Ltd.
MDCX.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.60% | -238.98% | -21.04% | -44.27% | -55.20% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | -75.34% | 4,443.05% | 151.47% | 65.41% | 165.70% |
| Change in Net Operating Assets | 146.88% | -626.18% | -75.24% | 290.15% | 130.78% |
| Cash from Operations | 2.20% | -23.57% | -38.77% | -23.48% | -2.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 63.70% | -- | -- | -- |
| Total Debt Repaid | 68.90% | -- | -- | -- | -- |
| Issuance of Common Stock | -5.94% | 29.04% | 84.54% | 84.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 81.26% | -12.61% | -1,209.60% | -- | -- |
| Cash from Financing | -35.85% | -7.03% | 196.77% | 83.40% | -- |
| Foreign Exchange rate Adjustments | 29.41% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.28% | -117.72% | 3,226.50% | 84.07% | 63.19% |